COVID-19 Impact on Becton Dickinson & Co.’s Revenue and Operations (Medical Devices)


Summary

Becton Dickinson & Co. (BD) is a medical technology company which designs, develops, manufactures and delivers medical supplies, devices, laboratory equipment and diagnostic products all around the world. Becton Dickinson & Co. (BD)’s product portfolio includes products which can be mainly divided into medical, interventional and life sciences segments. Some examples are diagnostic systems, surgical, and peripheral intervention products. The report, COVID-19 Impact on Becton Dickinson & Co.’s Revenue and Operations (Medical Devices) presents a deep dive analysis into how Becton Dickinson & Co. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Becton Dickinson & Co. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.


Key Highlights

  • According to Becton Dickinson & Co. (BD)’s 2020 second fiscal quarter results, ending on March 31st 2020, Becton Dickinson & Co. (BD) was able to deliver an increase of 1.4% in revenues, despite the negative impact of COVID-19.
  • The rise in COVID-19 cases, especially in the US, has negatively impacted the outlook of sales for certain sectors of Becton Dickinson & Co. (BD)’s business.
  • Due to the COVID-19 pandemic, Becton Dickinson & Co. (BD) has withdrawn their fiscal year 2020 guidance.




Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Becton Dickinson & Co. -

  • It provides insights on Becton Dickinson & Co.’s exposure to the regions and businesses impacted by the COVID-19 outbreak.
  • It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.




Reasons To Buy

  • An overview of how Becton Dickinson & Co. will be affected by the COVID-19 pandemic.